NCT02173158View on ClinicalTrials.gov

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 2, 2014

Primary Completion Date

April 3, 2015

Study Completion Date

December 17, 2015

Conditions
Familial Hypercholesterolemia - Homozygous
Interventions
DRUG

lomitapide

Trial Locations (6)

830-8522

Kurume-shi

920-8641

Kanazawa

530-00001

Osakashi

565-8565

Suita-shi

359-1142

Tokorozawa

113-8519

Bunkyo-ku

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT02173158 - Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy | Biotech Hunter | Biotech Hunter